Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry encodes a **pseudogene** for subunit c of the mitochondrial F0 complex of ATP synthase (specifically isoform 2). Pseudogenes are nonfunctional gene copies often created by duplication or retrotransposition, typically with coding-sequence deficiencies (frameshifts, premature stop codons), and do not produce active proteins[2][4]. The functional version, ATP5MC2, is part of the mitochondrial ATP synthase proton channel, crucial for ATP generation by oxidative phosphorylation[3][1]. Pseudogenes like ENSG00000230820 may have regulatory roles in genome evolution or gene expression, but are not currently considered drug targets or relevant for direct disease associations[2][4].
None for this pseudogene. (Drugs targeting mitochondrial ATP synthase generally interfere with proton transport or ATP generation, but only for the active protein.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase H+ transporting mitochondrial F0 complex subunit c isoform 2 pseudogene.